Clik here to view.
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global...
PLEASANTON, Calif. & NANJING, China & SHANGHAI IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative...
View ArticleClik here to view.
DESTINY-Gastric06 Phase 2 Trial of ENHERTU® Initiated in China in Patients...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced that the first patient was dosed in DESTINY-Gastric06, a...
View ArticleClik here to view.
Virpax® Pharmaceuticals宣布公开发行总额4000万美元的普通股
宾夕法尼亚州伯温 (美国商业资讯)–疼痛管理药品专业开发公司Virpax® Pharmaceuticals Inc.（“Virpax”或“公司”）...
View ArticleClik here to view.
Tarveda Therapeutics and SciClone Pharmaceuticals Expand Partnership by...
WATERTOWN, Mass. Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as...
View ArticleClik here to view.
DS-7300 Data at ESMO Shows Promising Early Clinical Activity in Patients with...
TOKYO & MUNICH & BASKING RIDGE, N.J. New first-in-human data from DS-7300, a B7-H3 directed DXd antibody drug conjugate (ADC) being developed in strategic collaboration between Daiichi...
View ArticleClik here to view.
Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to...
REYKJAVIK, Iceland Alvotech today welcomed the positive opinion of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending the approval of Alvotech‘s...
View ArticleClik here to view.
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the...
BASEL, Switzerland & CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
View ArticleClik here to view.
Clik here to view.
Masimo上市单例患者使用的rainbow® SuperSensor™
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，单例患者使用的粘贴式rainbow® SuperSensor™获得CE认证并在欧洲上市，该产品兼容Masimo和内置Masimo...
View ArticleClik here to view.
武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
日本大阪和马萨诸塞州剑桥 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（简称“武田”）今天宣布，美国食品药品管理局(FDA)已核准EXKIVITY...
View ArticleClik here to view.
ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients...
TOKYO & MUNICH & BASKING RIDGE, N.J. Detailed results from the positive DESTINY-Gastric02 phase 2 trial showed that ENHERTU® (trastuzumab deruxtecan), the Daiichi Sankyo Company, Limited...
View ArticleClik here to view.
ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus...
TOKYO & MUNICH & BASKING RIDGE, N.J. Detailed positive results from the head-to-head DESTINY-Breast03 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan), the Daiichi Sankyo Company,...
View ArticleClik here to view.
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59)...
INCHEON, South Korea Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended...
View ArticleClik here to view.
Virpax® Pharmaceuticals宣布完成公开发行总额4000万美元的普通股
宾夕法尼亚州伯温 (美国商业资讯)–疼痛管理药品专业开发公司Virpax® Pharmaceuticals Inc.（“Virpax”或“公司”）...
View ArticleClik here to view.
Clik here to view.
City of Hope and Griffith University Researchers Use Novel Method to Block...
DUARTE, Calif. Researchers at City of Hope, a world-renowned research and treatment organization for cancer and diabetes, and Menzies Health Institute Queensland at Griffith University have...
View ArticleClik here to view.
武田薬品のEXKIVITY™（モボセルチニブ）がEGFRエクソン20挿入変異陽性NSCLC患者向けに特別設計した初の経口治療薬として米国FDAの承認を取得
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
Celltrionのモノクローナル抗体治療薬、Regdanvimab(CT-P59)は、韓国食品医薬品安全庁(MFDS)からCOVID-19感染症治療薬と...
INCHEON, South Korea （ビジネスワイヤ） — Celltrion...
View ArticleClik here to view.
Clik here to view.
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to...
SAN DIEGO Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease...
View Article